Company & Sponsor Intelligence

NYU Langone Health

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials27

Recruiting3

Completed19

Countries1

Therapeutic footprint

adhdalzheimersepilepsymultiple_sclerosisother_neurologyother_psychiatrypain_neuropathyparkinsonssubstance_use

Indexed studies

NCT00381407Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
adhd · United StatesNA

NCT04784416Transcranial Photobiomodulation for Alzheimer's Disease (TRAP-AD)
alzheimers · United StatesPHASE2

NCT02749422fMRI Guided TMS Enhancement of Associative Memory Networks
epilepsy · United StatesNA

NCT00468143A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall
adhd · United StatesPHASE4

NCT02347202Tools for Distance Delivery of an Evidence-based AD Family Caregiver Intervention
alzheimers · United StatesNA

NCT02451696A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD
epilepsy · United StatesPHASE2

NCT02268578Efficacy of TDCS for Treating Working Memory Dysfunction and Depression in Temporal Lobe Epilepsy
epilepsy · United StatesPHASE1

NCT05615922Remotely Supervised Transcranial Direct Current Stimulation (tDCS) for Primary Progressive Aphasia (PPA)
other_psychiatry · United StatesPHASE2

NCT02741193Presurgical Motor Mapping With Transcranial Magnetic Stimulation (TMS)
epilepsy · United StatesNA

NCT02474251Brain Sleep Clearance of Amyloid-Beta Peptides
alzheimers · United StatesNA

NCT02983006Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma
parkinsons · United StatesPHASE1

NCT04218201Subthreshold Opioid Use Disorder Prevention (STOP) Trial
substance_use · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →